Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$6.69 - $9.0 $28,098 - $37,800
-4,200 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$8.26 - $11.4 $6,608 - $9,120
800 Added 23.53%
4,200 $34,000
Q4 2020

Feb 11, 2021

SELL
$8.21 - $18.59 $16,420 - $37,180
-2,000 Reduced 37.04%
3,400 $29,000
Q3 2020

Oct 30, 2020

BUY
$11.33 - $19.81 $61,182 - $106,974
5,400 New
5,400 $100,000

Others Institutions Holding MESO

About MESOBLAST LTD


  • Ticker MESO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 147,316,000
  • Market Cap $1.2B
  • Description
  • Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...
More about MESO
Track This Portfolio

Track Steward Partners Investment Advisory, LLC Portfolio

Follow Steward Partners Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.